dPCR LNA Mutation Assays

For detecting specific DNA sequence mutations related to cancer and oncogenesis

  • Duplex assay design detects mutated and wild-type sequences
  • Choice of FAM + HEX or Atto 550 + ROX fluorescent dye combinations
  • LNA-enhanced primers and probes increase assay specificity and sensitivity
  • Wet-lab tested dPCR assays available for more than 200 targets
  • Suitable for use with circulating tumor DNA, liquid biopsy, FFPE and other tissue samples
  • Intended for use with QIAcuity Probe PCR Kits

Product

Product List4 products

GeneGlobe ID: DMH0000571 | Cat. No.: | dPCR LNA Mutation Assays
dPCR Mutation Assay ABL1 12576 Human
AA Mutation: p.Y272H
Nucleotide Mutation: c.814T>C
dPCR wet-lab validated
Product Specification
GeneGlobe ID: DMH0000306 | Cat. No.: | dPCR LNA Mutation Assays
dPCR Mutation Assay ABL1 12560 Human
AA Mutation: p.T334I
Nucleotide Mutation: c.1001C>T
dPCR wet-lab validated
Product Specification
GeneGlobe ID: DMH0000573 | Cat. No.: | dPCR LNA Mutation Assays
dPCR Mutation Assay ABL1 12573 Human
AA Mutation: p.E274K
Nucleotide Mutation: c.820G>A
dPCR wet-lab validated
Product Specification
GeneGlobe ID: DMH0000053 | Cat. No.: | dPCR LNA Mutation Assays
dPCR Mutation Assay ABL1 12574 Human
AA Mutation: p.E274V
Nucleotide Mutation: c.821A>T
dPCR wet-lab validated
Product Specification
You've viewed 4 of 4 Products
Load more products

Resources

Instrument User Manuals (1)
Quick-Start Protocols (1)
Safety Data Sheets (1)
Application Notes (1)
Digital PCR (dPCR) is a powerful technique that detects and quantifies ultra-rare mutations in a high background of wild-type cfDNA down to 0.1% variant allele frequency. Here, we describe end-to-end manual and automated workflows that enable accurate detection and absolute quantification of ultra-rare PIK3CA variants in cfDNA using the QIAcuity Digital PCR System.
Certificates of Analysis (1)